Monday, August 29, 1994
WASHINGTON - Proposals for streamlined procedures for human gene therapy protocols,
eliminating overlap between the NIH's Recombinant DNA Advisory Committee and the FDA, will
be discussed at the RAC's meeting on Sept. 12-13.
The proposals, published last week in the Federal Register, emanate from a July meeting of
the National Task Force on AIDS Drug Development, which was held to indentify barriers to
AIDS drug discovery. Task Force